Vol 15 No 4 |
Tips and Hints for Quality
Compounding |
Vol 15 No 3 |
Beyond-Use Dates and Stability
Indicating Assay Methods in Pharmaceutical Compounding |
Vol 15 No 2 |
Compounding with Hazardous Drugs |
Vol 15 No 1 |
Stability of Extemporaneously
Prepared Oral Liquid Formulations - Part VI |
Vol 14 No 4 |
Compounding Rectal Dosage Forms
- Part II |
Vol
14 No 3 |
Stability of Extemporaneously
Prepared Oral Liquid Formulations - Part V |
Vol
14 No 2 |
Compounding Rectal Dosage Forms,
Part 1 |
Vol 14 No 1 |
Stability of Extemporaneously Prepared Oral Liquid
Formulations - Part IV
|
Vol 13 No 4 |
USP Chapter <795> Pharmaceutical Compounding -
Nonsterile Preparations
|
Vol 13 No 3 |
Compounding for Lacquers, Varnishes,
Collodions and Protectants
|
Vol 13 No 2 |
Compounding for Gastrointestinal
Disorders
|
Vol 13 No 1 |
Compounding for Otic Disorders
|
Vol 12 No 4 |
Compounding for Sports Injuries
|
Vol 12 No 3 |
Compounding for Glycerin & Propylene Glycol
|
Vol 12 No 2 |
Compounding for Scalp Disorder
|
Vol 12 No 1 |
Compounding for Wound Care |
Vol 11 No 4 |
Compounding for Superficial Fungal Infections |
Vol 11 No 3 |
A History of Pharmaceutical Compounding |
Vol 11 No 2 |
Compounding for Phonophoresis |
Vol 11 No 1 |
Compounding for Acne |
Vol 10 No 4 |
Compounding for Iontophoresis |
Vol 10 No 3 |
Compounding for Dermatology Patients |
Vol 10 No 2 |
Compounding for Dentists and Dental Patients |
Vol 10 No 1 |
Pharmaceutical Compounding Resources on the Internet |
Vol 9 No 4 |
Compounding for Patients with Psoriasis |
Vol 9 No 3 |
Compounding for Diabetic Patients |
Vol 9 No 2 |
Compounding For Hospice Patients |
Vol 9 No 1 |
Compounding For Geriatric And Arthritis Patients |
Vol 8 No 4 |
Compounding For The Management Of Pain |
Vol 8 No 3 |
Need For Extemporaneous Formulations In Pediatric Patients |
Vol 8 No 2 |
Compounding For Male Andropause |
Vol 8 No 1 |
Compounding For Hormone Replacement Therapy |
Vol 7 No 4 |
Packaging, Storage and Distribution of Compounded Pharmaceuticals |
Vol 7 No 3 |
Compounding, Stability and Beyond-Use Dates |
Vol 7 No 2 |
Veterinary Compounding |
Vol 7 No 1 |
Compounding Nasal Preparations |
Vol 6 No 4 |
Compounding Ophthalmic Liquids |
Vol 6 No 3 |
Inhalation Products |
Vol 6 No 2 |
Stability of Extemporaneously Prepared Pediatric Formulations Using Ora-Plus® with Ora-Sweet® and Ora-Sweet® SF- Part III |
Vol 6 No 1 |
Stability of Extemporaneously Prepared Pediatric Formulations Using Ora-Plus® with Ora-Sweet® and Ora-Sweet® SF - Part II |
Vol 5 No 4 |
Stability of Extemporaneously Prepared Pediatric Formulations Using Ora-Plus® with Ora-Sweet® and Ora-Sweet® SF - Part I |
Vol 5 No 3 |
Compounding Medication Sticks |
Vol 5 No 2 |
Pharmaceutical Compounding Calculations |
Vol 5 No 1 |
Pharmaceutical Compounding Tips and Hints |
Vol 4 No 6 |
General "Good Manufacturing Practices" for Nonsterile Products |
Vol 4 No 5 |
Compounding Gels |
Vol 4 No 4 |
Compounding Capsules |
Vol 4 No 3 |
Pharmacy Compounding Equipment |
Vol 4 No 2 |
Troches and Lozenges |
Vol 4 No 1 |
Emulsions |
Vol 3 No 4 |
Compounding Suppositories: Part II |
Vol 3 No 3 |
Compounding Suppositories: Part I |
Vol 3 No 2 |
Compounding Topical Dosage Forms: Ointments, Creams, Pastes and Lotions |
Vol 3 No 1 |
Compounding Oral Liquids |
Vol 2 No 1 |
Preparation of Oral Suspensions and Syrups: Basic Concepts |
Vol 1 No 2 |
Topical Antibiotic Dosage Forms |
Vol 1 No 1 |
Ointment Compounding: Basic Concepts |